Combining Radiomics and Autoencoders to Distinguish Benign and Malignant Breast Tumors on US Images.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 10 9 2024
Statut: ppublish

Résumé

Background US is clinically established for breast imaging, but its diagnostic performance depends on operator experience. Computer-assisted (real-time) image analysis may help in overcoming this limitation. Purpose To develop precise real-time-capable US-based breast tumor categorization by combining classic radiomics and autoencoder-based features from automatically localized lesions. Materials and Methods A total of 1619 B-mode US images of breast tumors were retrospectively analyzed between April 2018 and January 2024. nnU-Net was trained for lesion segmentation. Features were extracted from tumor segments, bounding boxes, and whole images using either classic radiomics, autoencoder, or both. Feature selection was performed to generate radiomics signatures, which were used to train machine learning algorithms for tumor categorization. Models were evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity and were statistically compared with histopathologically or follow-up-confirmed diagnosis. Results The model was developed on 1191 (mean age, 61 years ± 14 [SD]) female patients and externally validated on 50 (mean age, 55 years ± 15]). The development data set was divided into two parts: testing and training lesion segmentation (419 and 179 examinations) and lesion categorization (503 and 90 examinations). nnU-Net demonstrated precision and reproducibility in lesion segmentation in test set of data set 1 (median Dice score [DS]: 0.90 [IQR, 0.84-0.93];

Identifiants

pubmed: 39254446
doi: 10.1148/radiol.232554
doi:

Banques de données

ClinicalTrials.gov
['NCT04976257']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e232554

Auteurs

Zuzanna Anna Magnuska (ZA)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Rijo Roy (R)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Moritz Palmowski (M)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Matthias Kohlen (M)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Brigitte Sophia Winkler (BS)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Tatjana Pfeil (T)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Peter Boor (P)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Volkmar Schulz (V)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Katja Krauss (K)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Elmar Stickeler (E)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Fabian Kiessling (F)

From the Institute for Experimental Molecular Imaging (Z.A.M., R.R., M.P., V.S., F.K.), Institute of Pathology (P.B.), and Department of Obstetrics and Gynecology (M.K., B.S.W., T.P., K.K., E.S.), University Clinic Aachen, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Physics Institute III B, RWTH Aachen University, Aachen, Germany (V.S.); Comprehensive Diagnostic Center Aachen, Uniklinik RWTH Aachen, Aachen, Germany (P.B., V.S., E.S., F.K.); and Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (P.B., V.S., F.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH